Description

Ranitidin-Darnitsa Coated Tablets 0.15 g. №20

Ingredients:

Each coated tablet contains 0.15 g of Ranitidine.

Dosage:

The usual dosage is one tablet orally twice a day.

Indications:

Ranitidin-Darnitsa is indicated for the treatment of duodenal ulcers, benign gastric ulcers, reflux esophagitis, and Zollinger-Ellison syndrome.

Contraindications:

Do not use Ranitidin-Darnitsa if you are allergic to ranitidine or any other ingredients in the product.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence:

Ranitidine, the active ingredient in Ranitidin-Darnitsa, is a histamine-2 receptor antagonist that works by reducing the amount of acid produced by the stomach. Several studies have demonstrated the efficacy of ranitidine in treating various gastrointestinal conditions.

Additional Information:

Ranitidin-Darnitsa coated tablets provide effective relief from acid-related conditions and are well-tolerated by most patients. It is important to follow the prescribed dosage and consult a healthcare professional if you have any concerns or experience adverse reactions.

Research has shown that ranitidine is as effective as other commonly used medications in the treatment of ulcers and gastroesophageal reflux disease. It is considered a safe and cost-effective option for managing these conditions.